The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.
https://www.moleculardxeurope.com/
Eine durchschnittliche Folge dieses Podcasts dauert 8m.
Bisher sind 255 Folge(n) erschienen.
.
Gesamtlänge aller Episoden: 1 day 14 hours 15 minutes
PEGS Boston 2018 | How to Interpret and Implement FDA Guidelines for Biologics?
Dr. William Hallett outlines what he considers so…
PEGS Boston 2018 | An interview with the 2018 Young Scientist Keynote, Dr. Kipp Weiskopf
An interview with the 2018 Young Scientist Keynot…
SCOPE 2018 | Clinical Trial Contracting Challenges
Débora Araujo of Boehringer Ingelheim spoke to CH…
PepTalk 2018 | Remodeling of Cell Surfaceomes in Cancer
Dr. Wells, Professor of Pharmaceutical Chemistry …
ImPACT 2017 | Targeting the Hypoxic Tumor Microenvironment
In this podcast from CHI on September 20, 2017, S…
Bio-IT World | Accelerate Real World Evidence: Leveraging Data for Faster Time to Insight
Real World Evidence (RWE) is today’s big data cha…
ImPACT 2017 | What Will the IMPACT of the Microbiome be on Cancer Immunotherapy?
In this podcast from CHI on September, Vancheswar…
Advances in Prenatal Molecular Diagnostics 2017 | Fetal Whole Exome Sequencing
Dr. Neeta Vora of University of North Carolina Ch…
PEGS Europe 2017 | The Next Generation of Antibody-Drug Conjugates (ADCs)
This podcast highlights the Plenary Keynote prese…
Discovery on Target 2017 | Small Molecule Ubiquitin Protease (USP7) Inhibitors
Tauseef Butt, CEO of Progenra Inc. speaks to CHI …